𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Study of Combined 5-Fluorouracil/ Ginkgo biloba Extract (GBE 761 ONC) Therapy in 5-Fluorouracil Pretreated Patients with Advanced Colorectal Cancer

✍ Scribed by B. Hauns; B. Häring; S. Köhler; K. Mross; C. Unger


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
782 KB
Volume
15
Category
Article
ISSN
0951-418X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A phase II trial of weekly high dose con
✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

Phase II study of 5-fluorouracil and fol
✍ Giuseppe Colucci 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 3 views

n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our